SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Sclerosteosis is an autosomal recessive disease that is characterized by overgrowth of bone tissue and is linked to mutations in the gene encoding the secreted protein SOST. Sclerosteosis shares remarkable similarities with "high bone mass" diseases caused by "gain-of-function" mutations in the LRP5 gene, which encodes a coreceptor for Wnt signaling proteins. We show here that SOST antagonizes Wnt signaling in Xenopus embryos and mammalian cells by binding to the extracellular domain of the Wnt coreceptors LRP5 and LRP6 and disrupting Wnt-induced Frizzled-LRP complex formation. Our findings suggest that SOST is an antagonist for Wnt signaling and that the loss of SOST function likely leads to the hyperactivation of Wnt signaling that underlies bone overgrowth seen in sclerosteosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The SOST protein can also bind to LRP5/6 where it can antagonize Wnt signaling.25”
From Wnt signal transduction pathways (2008) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
LDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128
Self-citationOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
An LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Cited by
Items 201–300 of 859
Destroy to Rebuild: The Connection Between Bone Tissue Remodeling and Matrix Metalloproteinases
Hardy, E., & Fernández-Patrón, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00047 · Cited by 94
Mef2c deletion in osteocytes results in increased bone mass
Kramer, I., Baertschi, S., Halleux, C., Keller, H., & Kneissel, M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1492 · Cited by 85
Bone biology, signaling pathways, and therapeutic targets for osteoporosis
Iñiguez‐Ariza, N. M., & Clarke, B. L. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.07.003 · Cited by 94
Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone
Pérez-Campo, F. M., Santurtún, A., García‐Ibarbia, C., Pascual, M. A., Valero, C., Garcés, C. M., Sañudo, C., Zarrabeitia, M. T., & Riancho, J. A. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0144-4 · Cited by 93
New insights on the roles of BMP signaling in bone—A review of recent mouse genetic studies
Kamiya, N., & Mishina, Y. M. (2011) · BioFactors · doi:10.1002/biof.139 · Cited by 92
Ahn, Y., Sims, C., Logue, J. M., Weatherbee, S. D., & Krumlauf, R. (2013) · Development · doi:10.1242/dev.085118 · Cited by 79
Zhang, B., Abreu, J. G., Zhou, K., Chen, Y., Hu, Y., Zhou, T., He, X., & Ma, J.-X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906764107 · Cited by 85
Self-citationSclerostin levels during growth in children
Kirmani, S., Amin, S., McCready, L. K., Atkinson, E. J., Melton, L. J., Müller, R., & Khosla, S. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1669-z · Cited by 79
NMR structure of the Wnt modulator protein Sclerostin
Weidauer, S. E., Schmieder, P., Beerbaum, M., Schmitz, W., Oschkinat, H., & Mueller, T. D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.062 · Cited by 89
Prideaux, M., Loveridge, N., Pitsillides, A. A., & Farquharson, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036786 · Cited by 89
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Kim, J., Han, W., Park, T., Kim, E., Bang, I., Lee, H. S., Jeong, Y., Roh, K., Kim, J., Kim, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19155-4 · Cited by 88
Glantschnig, H., Scott, K., Hampton, R. A., Wei, N., McCracken, P. J., Nantermet, P. V., Zhao, J. Z., Vitelli, S., Huang, L., Haytko, P., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181404 · Cited by 88
Saxon, L. K., Jackson, B. F., Sugiyama, T., Lanyon, L. E., & Price, J. S. (2011) · Bone · doi:10.1016/j.bone.2011.03.683 · Cited by 84
Fijalkowski, I., Geets, E., Steenackers, E., Van Hoof, V., Ramos, F. J., Mortier, G., Fortuna, A. M., Van Hul, W., & Boudin, E. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2782 · Cited by 82
The Utility of Biomarkers in Osteoporosis Management
Garnero, P. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0272-1 · Cited by 88
Epigenetics and Bone Remodeling
Husain, A., & Jeffries, M. A. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0391-y · Cited by 81
Riquelme, M. A., Gu, S., Hua, R., & Jiang, J. X. (2021) · Bone Research · doi:10.1038/s41413-020-00126-w · Cited by 86
Targeting the LRP5 Pathway Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta
Jacobsen, C. M., Barber, L. A., Ayturk, U. M., Roberts, H. J., Deal, L. E., Schwartz, M. A., Weis, M., Eyre, D., Zurakowski, D., Robling, A. G., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2198 · Cited by 83
Ayturk, U. M., Jacobsen, C. M., Christodoulou, D. C., Gorham, J., Seidman, J. G., Seidman, C. E., Robling, A. G., & Warman, M. L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1946 · Cited by 84
The Structural Basis of DKK-Mediated Inhibition of Wnt/LRP Signaling
Bao, J., Zheng, J., & Wu, D. (2012) · Science Signaling · doi:10.1126/scisignal.2003028 · Cited by 84
Transcriptional control of Sost in bone
Sebastian, A., & Loots, G. G. (2017) · Bone · doi:10.1016/j.bone.2016.10.009 · Cited by 80
Structural perspective of BMP ligands and signaling
Gipson, G. R., Goebel, E. J., Hart, K. N., Kappes, E. C., Kattamuri, C., McCoy, J. C., & Thompson, T. B. (2020) · Bone · doi:10.1016/j.bone.2020.115549 · Cited by 70
Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
Rauner, M., Taipaleenmäki, H., Tsourdi, E. A., & Winter, E. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040787 · Cited by 83
Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
Genetos, D. C., Yellowley, C. E., & Loots, G. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017772 · Cited by 83
Yu, J., & Virshup, D. M. (2014) · Bioscience Reports · doi:10.1042/bsr20140119 · Cited by 81
Sclerostin Enhances Adipocyte Differentiation in 3T3‐L1 Cells
Ukita, M., Yamaguchi, T., Ohata, N., & Tamura, M. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25432 · Cited by 80
The evolving biology of small molecules: controlling cell fate and identity
Efe, J. A., & Ding, S. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0006 · Cited by 81
Bone Biology and Anabolic Therapies for Bone: Current Status and Future Prospects
Martin, T. J. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.1.8 · Cited by 81
Nioi, P., Taylor, S., Hu, R., Pacheco, E., He, Y. D., Hamadeh, H., Paszty, C., Pyrah, I., Ominsky, M. S., & Boyce, R. W. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2482 · Cited by 74
Zhang, B., Zhou, K. K., & Ma, J.-X. (2010) · Diabetes · doi:10.2337/db09-1056 · Cited by 80
Sclerostin Inhibition in the Management of Osteoporosis
Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0126-6 · Cited by 80
Niches for Skeletal Stem Cells of Mesenchymal Origin
Kurenkova, A. D., Medvedeva, E. V., Newton, P. T., & Chagin, A. S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00592 · Cited by 80
Chang, M.-K., Krämer, I., Keller, H., Gooi, J. H., Collett, C., Jenkins, D., Ettenberg, S. A., Cong, F., Halleux, C. M., & Kneissel, M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2059 · Cited by 79
Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp5-Deficient Mouse Model of OPPG Syndrome
Kedlaya, R., Veera, S. S., Horan, D. J., Moss, R. E., Ayturk, U. M., Jacobsen, C. M., Bowen, M. E., Pászty, C., Warman, M. L., & Robling, A. G. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006627 · Cited by 79
Gatti, D., Viapiana, O., Adami, S., Idolazzi, L., Fracassi, E., & Rossini, M. (2011) · Bone · doi:10.1016/j.bone.2011.11.028 · Cited by 79
Circulating Sclerostin in Disorders of Parathyroid Gland Function
Costa, A. G., Cremers, S., Rubin, M. R., McMahon, D. J., Sliney, J., Lazaretti‐Castro, M., Silverberg, S. J., & Bilezikian, J. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0566 · Cited by 79
Jäger, A., Götz, W., Lossdörfer, S., & Rath-Deschner, B. (2009) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2009.01227.x · Cited by 78
The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Wagner, E. R., Zhu, G., Zhang, B., Luo, Q., Shi, Q., Huang, E., Gao, Y., Gao, J., Kim, S. H., Rastegar, F., et al. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104010014 · Cited by 78
Role of the Wnt signaling molecules in the tooth
Tamura, M., & Nemoto, E. (2016) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2016.04.001 · Cited by 78
Ota, K., Quint, P., Ruan, M., Pederson, L., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24537 · Cited by 70
TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition
Kim, B., Bae, S. J., Lee, S.-Y., Lee, Y., Baek, J., Park, S., Lee, S. H., Koh, J., & Kim, G. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.100 · Cited by 76
Mechanical Force–induced TGFB1 Increases Expression of SOST/POSTN by hPDL Cells
Manokawinchoke, J., Limjeerajarus, N., Limjeerajarus, C. N., Sastravaha, P., Everts, V. E., & Pavasant, P. (2015) · Journal of Dental Research · doi:10.1177/0022034515581372 · Cited by 76
Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0087-0 · Cited by 76
The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia
Chiarini, F., Paganelli, F., Martelli, A. M., & Evangelisti, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031098 · Cited by 76
Disease modification in ankylosing spondylitis
Maksymowych, W. P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.258 · Cited by 75
HIF-1α Inhibits Wnt Signaling Pathway by Activating Sost Expression in Osteoblasts
Chen, D., Li, Y., Zhou, Z., Wu, C., Xing, Y., Zou, X., Tian, W., & Zhang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065940 · Cited by 74
Sclerostin: Therapeutic Horizons Based Upon Its Actions
Costa, A. G., & Bilezikian, J. P. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0089-5 · Cited by 74
Drug discovery of sclerostin inhibitors
Yu, S., Li, D., Zhang, N., Ni, S., Sun, M., Wang, L., Xiao, H., Liu, D., Liu, J., Yu, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.012 · Cited by 73
Chung, Y., Lee, S. H., Lee, S.-Y., Kim, S.-Y., Kim, H.-H., Mirza, F., Lee, S.-K., Lorenzo, J. A., Kim, G. S., & Koh, J. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1675-1 · Cited by 73
Signaling Pathways in Human Skeletal Dysplasias
Baldridge, D., Shchelochkov, O. A., Kelley, B., & Lee, B. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150158 · Cited by 73
First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function
Piters, E., Çulha, C., Moester, M. J. C., Bezooijen, R. V., Adriaensen, D., Mueller, T. D., Weidauer, S. E., Jennes, K., de Freitas, F., Löwik, C., et al. (2010) · Human Mutation · doi:10.1002/humu.21274 · Cited by 73
Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
Marom, R., Lee, Y., Grafe, I., & Lee, B. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31532 · Cited by 72
The role of APC in WNT pathway activation in serrated neoplasia
Borowsky, J., Dumenil, T. D., Bettington, M. L., Pearson, S., Bond, C., Fennell, L., Liu, C., McKeone, D., Rosty, C., Brown, I., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.150 · Cited by 72
WNT signaling and chondrocytes: from cell fate determination to osteoarthritis physiopathology
Sassi, N., LAADHAR, L., Allouche, M., Achek, A., KALLEL‐SELLAMI, M., Makni, S., & Sellami, S. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.863919 · Cited by 71
Niziolek, P. J., Farmer, T. L., Cui, Y., Turner, C. H., Warman, M. L., & Robling, A. G. (2011) · Bone · doi:10.1016/j.bone.2011.07.034 · Cited by 72
Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging
Chen, D., Xie, R., Shu, B., Landay, A. L., Wei, C., Reiser, J., Spagnoli, A., Torquati, A., Forsyth, C. B., Keshavarzian, A., et al. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13945 · Cited by 69
Secreted WNT antagonists as tumor suppressors: pro and con
Jeffrey, S. R. (2006) · Frontiers in bioscience · doi:10.2741/1952 · Cited by 69
Holdsworth, G., Greenslade, K. J., Jose, J., Stencel, Z., Kirby, H., Moore, A., Ke, H. Z., & Robinson, M. K. (2017) · Bone · doi:10.1016/j.bone.2017.11.003 · Cited by 69
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
Schulze, J., Seitz, S., Saito, H., Schneebauer, M., Marshall, R. P., Baranowsky, A., Busse, B., Schilling, A. F., Friedrich, F. W., Albers, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010309 · Cited by 62
Miyagawa, K., Yamazaki, M., Kawai, M., Nishino, J., Koshimizu, T., Ohata, Y., Tachikawa, K., Mikuni‐Takagaki, Y., Kogo, M., Ozono, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093840 · Cited by 67
The Bone Morphogenetic Proteins and Their Antagonists
Mulloy, B., & Rider, C. C. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2015.06.004 · Cited by 67
Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation
Ding, Y., Xi, Y., Chen, T., Wang, J.-Y., Tao, D.-L., Wu, Z.-L., Li, Y.-P., Li, C., Zeng, R., & Li, L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803147 · Cited by 62
TGF-β regulates sclerostin expression via the ECR5 enhancer
Loots, G. G., Keller, H., Leupin, O., Murugesh, D. K., Collette, N. M., & Genetos, D. C. (2011) · Bone · doi:10.1016/j.bone.2011.11.016 · Cited by 66
Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
Delanaye, P., Krzesinski, J.-M., Warling, X., Moonen, M., Smelten, N. S., Médart, L., Bruyère, O., Reginster, J., Pottel, H., & Cavalier, E. (2014) · Nephron Clinical Practice · doi:10.1159/000366449 · Cited by 65
van Dinther, M., Zhang, J., Weidauer, S. E., Boschert, V., Muth, E.-M., Knappik, A., de Gorter, D. J. J., van Kasteren, P. B., Frisch, C., Mueller, T. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062295 · Cited by 65
Chen, Q., Liu, W., Sinha, K. M., Yasuda, H., & Crombrugghe, B. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058104 · Cited by 64
Effects of inflammation on bone: an update
Baker-LePain, J. C., Nakamura, M. C., & Lane, N. E. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283474dbe · Cited by 63
Niziolek, P., Warman, M. L., & Robling, A. G. (2012) · Bone · doi:10.1016/j.bone.2012.05.023 · Cited by 63
Wnt signaling: the good and the bad
Chen, X., Yang, J., Evans, P. M., & Liu, C. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00440.x · Cited by 63
Signalling dynamics in embryonic development
Sonnen, K. F., & Janda, C. Y. (2021) · Biochemical Journal · doi:10.1042/bcj20210043 · Cited by 56
Mathavan, N., Singh, A., Marques, F. C., Günther, D., Kuhn, G. A., Wehrle, E., & Müller, R. (2025) · Science Advances · doi:10.1126/sciadv.adp8496 · Cited by 62
Chen, H., Xu, X., Liu, M., Zhang, W., Ke, H.-Z., Qin, A., Tang, T., & Lu, E. (2015) · Bone · doi:10.1016/j.bone.2015.04.002 · Cited by 62
Wan, M., Li, J., Herbst, K. J., Zhang, J., Yu, B., Wu, X., Qiu, T., Lei, W., Lindvall, C. J., Williams, B. O., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001464 · Cited by 62
Wnt modulation in bone healing
Schupbach, D., Comeau-Gauthier, M., Harvey, E., & Merle, G. (2020) · Bone · doi:10.1016/j.bone.2020.115491 · Cited by 60
Jeong, W., & Jho, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714330 · Cited by 60
Tan, S. H., Senarath-Yapa, K., Chung, M. T., Longaker, M. T., Wu, J. Y., & Nusse, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420463111 · Cited by 60
Members of the DAN Family Are BMP Antagonists That Form Highly Stable Noncovalent Dimers
Kattamuri, C., Luedeke, D. M., Nolan, K., Rankin, S. A., Greis, K. D., Zorn, A. M., & Thompson, T. B. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.10.003 · Cited by 60
Peng, X., He, J., Zhao, J., Wu, Y., Shi, X., Du, L., Nong, M., Zong, S., & Zeng, G. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1956 · Cited by 60
Single-Cell RNA Sequencing of Calvarial and Long-Bone Endocortical Cells
Ayturk, U. M., Scollan, J. P., Aytürk, D. G., Suh, E. S., Vesprey, A., Jacobsen, C. M., Pajevic, P. D., & Warman, M. L. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4052 · Cited by 60
Mechanotransduction pathways in bone pathobiology
Spyropoulou, A., Karamesinis, K., & Basdra, E. K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.010 · Cited by 60
Role of Wnt signaling in fracture healing
Xu, H., Duan, J., Ning, D., Li, J., Liu, R., Yang, R., Jiang, J. X., & Shang, P. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.12.193 · Cited by 59
Quarto, N., Behr, B., & Longaker, M. T. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0133 · Cited by 58
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
Pakula, H., Xiang, D., & Li, Z. (2017) · Cancers · doi:10.3390/cancers9020014 · Cited by 58
Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner
Collette, N. M., Yee, C. S., Murugesh, D. K., Sebastian, A., Taher, L., Gale, N. W., Economides, A. N., Harland, R. M., & Loots, G. G. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.08.015 · Cited by 58
Mesenchymal Progenitors and the Osteoblast Lineage in Bone Marrow Hematopoietic Niches
Panaroni, C., Tzeng, Y.-S., Saeed, H., & Wu, J. Y. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0190-7 · Cited by 57
Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development
Ahn, Y., Sims, C., Murray, M. J., Kuhlmann, P., Fuentes‐Antrás, J., Weatherbee, S. D., & Krumlauf, R. K. (2017) · Development · doi:10.1242/dev.150680 · Cited by 57
Mechanosignaling in Bone Health, Trauma and Inflammation
Knapik, D. M., Perera, P., Nam, J., Blazek, A. D., Rath, B., Leblebicioğlu, B., Das, H., Wu, L., Hewett, T. E., Agarwal, S., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5467 · Cited by 58
Lu, W., Liu, C.-C., Thottassery, J. V., Bu, G., & Li, Y. (2010) · Biochemistry · doi:10.1021/bi1001486 · Cited by 53
Sclerostin is a direct target of osteoblast-specific transcription factor osterix
Yang, F., Tang, W., So, S., Crombrugghe, B. D., & Zhang, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.128 · Cited by 57
Robertis, A. D., Valensin, S., Rossi, M., Tunici, P., Verani, M., Rosa, A. D., Giordano, C., Varrone, M., Nencini, A., Pratelli, C., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1176-t · Cited by 56
Self-citationDriehuis, E., & Clevers, H. C. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13758 · Cited by 56
Kim, S. P., Da, H., Li, Z., Kushwaha, P., Beil, C., Mei, L., Xiong, W.-C., Wolfgang, M. J., Clemens, T. L., & Riddle, R. C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006769 · Cited by 51
Huang, Q.-Y., Li, G. H., & Kung, A. W. C. (2009) · Bone · doi:10.1016/j.bone.2009.03.676 · Cited by 55
Heterotrimeric G proteins in the control of parathyroid hormone actions
Bastepe, M., Turan, S., & He, Q. W. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0221 · Cited by 55
Colditz, J., Thiele, S., Baschant, U., Niehrs, C., Bonewald, L. F., Hofbauer, L. C., & Rauner, M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3463 · Cited by 47
Yan, J.-Y., Tian, F., Wang, W., Cheng, Y., Song, H.-P., Zhang, Y., & Zhang, L. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.07.013 · Cited by 55
Capozzi, A., Manganelli, V., Riitano, G., Caissutti, D., Longo, A., Garofalo, T., Sorice, M., & Misasi, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030891 · Cited by 54
Jastrzebski, S., Kalinowski, J., Stolina, M., Mirza, F., Torreggiani, E., Kalajzic, I., Won, H. Y., Lee, S.-K., & Lorenzo, J. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1773 · Cited by 51
WNT pathways and upper limb anomalies
Al-Qattan, M. M. (2010) · Journal of Hand Surgery (European Volume) · doi:10.1177/1753193410380502 · Cited by 54
Crystal structure of R-spondin 2 in complex with the ectodomains of its receptors LGR5 and ZNRF3
Zebisch, M., & Jones, E. Y. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.05.008 · Cited by 54
Metadata
- Authors
- Semënov, M., Tamai, K., & He, X.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- He, Xi
- ORCID
- He, Xi
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 280
- Issue
- 29
- Pages
- 26770-26775
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002725330
- Cited by
- 771
- References
- 42
- Citations by year
- 2026: 20 · 2025: 9 · 2024: 22 · 2023: 32 · 2022: 32 · 2021: 36 · 2020: 42 · 2019: 29 · 2018: 34 · 2017: 44 · 2016: 50 · 2015: 53 · 2014: 51 · 2013: 51 · 2012: 50
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5555 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- W. M. Keck Foundation
- Uehara Memorial Foundation
- National Institutes of Health
- National Institute of General Medical Sciences (GM057603)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- sclerostin, sclerosteosis, LRP5, LRP6, Wnt signaling, ligand binding, bone overgrowth, high bone mass, gain-of-function mutations, Xenopus embryo
- MeSH terms
- Animals, Bone Diseases, Developmental, Cell Line, Embryo, Mammalian, Embryo, Nonmammalian, Genetic Markers, Humans, Ligands, Protein Binding, Proteins, Receptors, LDL, Transfection, Xenopus, Signal Transduction, Bone Morphogenetic Proteins, Body Patterning, LDL-Receptor Related Proteins, Intercellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Wnt Proteins, Frizzled Receptors, Low Density Lipoprotein Receptor-Related Protein-6, Low Density Lipoprotein Receptor-Related Protein-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.